• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

HBCU Lifestyle – Black College Living

  • HBCUs
    • What is an HBCU?
    • History
    • List of HBCUs
    • Notable Graduates
  • Jobs
  • Parents
    • HBCU Rankings
    • Black College Tours
    • Admissions
    • Financing
    • Scholarships
    • College Planning
  • Current Students
    • College Life
      • Greek Life
      • Sports
      • Dorm Living
      • College Survival
    • Careers
      • HBCU Career Hub
      • Internships
      • Career Profiles
      • Entrepreneur
    • Research Paper Resources
      • Research Paper Topics: 50 Ideas to Get Started
      • How To Write An Annotated Bibliography
      • Journalism Research Paper Resources
  • Alumni
    • HBCU Shirts
    • Podcast
    • Alumni Spotlight
    • HBCU Merch
    • Jobs
  • Shop
  • Facebook
  • Twitter
  • Instagram

You are here: Home / HBCUs / FAMU Researcher Receives Patent to Treat Cancers

HBCUs

FAMU Researcher Receives Patent to Treat Cancers

Source : famu.edu

TALLAHASSEE, Fla. – Nazarius Saah Lamango, an associate professor of medicinal chemistry in the Florida A&M University (FAMU) College of Pharmacy and Pharmaceutical Sciences, received a patent to treat cancers using compounds that block the activity of a unique enzyme. The activity of this enzyme is elevated in some tumors. Specifically, inhibiting the excess amounts of this enzyme would diminish its ability to process the target protein into the forms that promote tumor cell growth.

Lamango further explains how this patent can benefit society.

Dr. Nazarius Lamango

“The patent describes compounds that can be used to inhibit the activity of an enzyme that we have found to be abnormally high in the tumors of some patients,” said Lamango.  “By being able to use these compounds to bring the abnormally high enzyme activities in the tumors down to normal physiological levels, their ability to spur tumor growth will also be inhibited. When further developed into drugs, these compounds will constitute a new class of anticancer drugs with a novel mechanism of action.”

Lamango’s work was funded by grants from the National Institutes of Health (NIH). The NIH is the agency of the U.S. Federal Government tasked with managing the biomedical research budget.

According to Lamango, this enzyme, which is the target of the compounds described in the patent, is a member of a biochemical pathway for processing proteins, some of which regulate cell growth. Some of these proteins have been known for over a decade to play roles in some cancers and are said to be oncogenic, the potential of a gene to cause cancer.

Lamango explained that while conducting research on Parkinson’s disease, he found that this pathway may be involved, albeit in an opposite fashion, in degenerative disorders.

“It was astonishing that researchers have not paid more attention to the fact that degenerative disorders may share some common biochemical pathways with cancers,” he said.  “Suspecting that this key enzyme may be suppressed in degenerative disorders, we began making inhibitors that could be used to inhibit it and see if cultured nerve cells will degenerate in a similar fashion as in degenerative disorders. The thought that these inhibitors could be useful in anticancer treatment solidifies what we have been pursuing ever since.”

What inspired Lamango to pursue this patent?  He expressed that any research that will contribute to diminish cancer needs careful attention.

“I know people who have had cancer and passed away from the disease,” said Lamango.  “The thought of being diagnosed with a cancer is always scary. The statistics that more than 12 million people were diagnosed with cancer worldwide in 2008 and that more than 7 million people actually died from it is a daunting statistic.  According to the American Cancer Society Cancer Facts and Figures for 2010, 1.5 million cancer diagnosis and almost 600,000 cancer deaths were estimated to have occurred in the United States last year. Although Florida is only the fourth largest state in the U.S., population wise, it comes second only to California in the number of cancer diagnoses. Therefore, no matter how you look at it, cancer is never far from the mind. As a researcher, any thought or research finding that could lead to a contribution in diminishing the impact of cancer on society is always worthy of careful attention.”

Lamango is an individual that is no stranger to securing patents.  He has one patent that is licensed by a private biotechnology company.

In 2002, he received a patent (US patent number 6,372,793) regarding a method for treatment of a neurological disease characterized by an impaired neurological function. In 2006, it was licensed to Signum Bioscience, Inc.

Lamango received his bachelor of science degree in agricultural chemistry and a Ph.D. in biochemistry from the University of Leeds, United Kingdom.  He also received postdoctoral training from Louisiana State University Medical Center in New Orleans, La.

He holds memberships with the American Society for Biochemistry and Molecular Biology and the America Association for the Advancement of Science.

July 26, 2011 by HBCU Author

Primary Sidebar

Search

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Quick Links

  • Newsletter
  • Jobs and Internships
  • Shop
  • List of HBCUs by State
  • HBCU Rankings 2022
  • HBCU College Tours
  • Contact Us
  • About Us

HBCU History

  • The First HBCU in South
  • Oldest HBCUs In the Nation
  • The First Black Owned and Operated HBCU
  • The First and Only Black Catholic HBCU
  • 10 Powerful Black History Movies HBCU Students Should Watch

Popular Posts

  • Happy female college student working on research paper topics. Research Paper Topics: 50 Ideas to Get Started
  • Top 25 HBCU Rankings 2022 HBCU Rankings 2022: The Top 25 Black Colleges from U.S. News
  • HBCU Sororities and Fraternities to Consider The Divine 9: Sororities and Fraternities on HBCU Campuses
  • Meharry Medical College Located in Nashville, Tennessee HBCUs with Medical School Programs
  • Bowie State's nursing program students check a patient in class simulation. Top 10 HBCU Nursing Schools Rankings for 2022 by RN to BSN

Before Footer

Join Our HBCU Community

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Subscribe to our newsletter

Sign up to receive weekly HBCU news, jobs, and advice in your inbox.

Sign Me Up

Footer

About HBCU Lifestyle

The spirit and camaraderie of black college living is a lifestyle - the HBCU lifestyle! We're committed to keeping you connected to the black college living experience, bringing you the latest on everything, from scholarships and dorm living to Greek life and alumni giving.


Contact Us

Latest from the Blog

  • UNCF Expands HBCU Student Coaching Network
  • Tuskegee Engineering Students Win Awards at AMIE Design Challenge
  • Kauryn Datcher Receives Internship With Sandia National Labs
  • Virginia Union University Creates Center for Technology and Innovation
  • Newsletter
  • Jobs & Internships
  • Shop
  • List of HBCUs
  • HBCU Rankings
  • HBCU Scholarships
Copyright © 2010-2022 HBCU Lifestyle, LLC. All rights reserved.
Contact Us | Sitemap | Terms of Use | Privacy Policy
Get the best of the Black college experience delivered to your inbox.
Your email address:*
Name:*
Subscribe to (select all that apply):*





Please wait...
Please enter all required fields Click to hide
Correct invalid entries Click to hide
No spam, ever. Promise. Powered by FeedBlitz